Core Viewpoint - The company, Jiao Da Ang Li, is facing significant challenges as it reported a profit of only 1.77 million yuan for the first three quarters, while attempting to increase the president's salary by 40% to 910,000 yuan, which was ultimately rejected by shareholders [1][3]. Group 1: Financial Performance and Salary Proposal - The company reported a profit of 1.77 million yuan for the first three quarters of the year [1][3]. - A proposal to increase the president's salary by 40% to 910,000 yuan was not approved due to a majority of shareholders choosing to abstain from voting [1][3]. Group 2: Legal and Regulatory Issues - The company is currently involved in litigation with investors, with claims being filed by the Shanghai Huzi Law Firm [1][3]. - This is the second time the company has been investigated by regulators, with a prior penalty issued by the China Securities Regulatory Commission (CSRC) in November 2023 for failing to disclose reports in a timely manner [2][4]. - Investors who purchased shares between April 22, 2017, and April 26, 2023, or before July 11, 2025, and sold or still hold shares at a loss, may be eligible for compensation [2][4].

Core Viewpoint - The proposal to increase the salary of the company's president was not approved during the shareholders' meeting, despite the justification that the current salary has not been adjusted for years and does not align with market standards [1][3]. Group 1: Shareholders' Meeting Outcomes - The temporary shareholders' meeting held on December 30 aimed to review three proposals, including the appointment of an accounting firm, adjustment of the president's basic salary, and revision of the salary management system for directors and senior management [2]. - The proposal to adjust the president's salary was not passed due to nearly two-thirds of the valid votes opting to abstain [3]. Group 2: Salary Adjustment Details - The current basic salary for the president, set in 2016, is proposed to be increased from 650,000 yuan per year to 910,000 yuan per year, effective from September 1, 2025, which translates to an additional 21,700 yuan per month [3]. - The company stated that the salary adjustment is intended to enhance management effectiveness and motivate senior management for the long-term stable development of the company [3]. Group 3: Company Performance and Regulatory Issues - For the first three quarters of 2025, the company reported a revenue of 22.4 million yuan, a year-on-year decline of 5.25%, and a net profit attributable to shareholders of 1.7743 million yuan, down 73.67% year-on-year [4]. - The company is currently under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws, with no further results reported as of now [4].

Core Viewpoint - The proposal to increase the salary of the president of Jiaotong Angli was rejected during the shareholders' meeting despite the company's profit of 1.77 million yuan in the first three quarters of the year [1][4]. Group 1: Financial Performance - Jiaotong Angli reported a net profit of 1.77 million yuan for the first three quarters, representing a year-on-year decline of 73.67% [4][10]. - The company's net profit after deducting non-recurring items was a loss of 3.91 million yuan [4][10]. Group 2: Salary Adjustment Proposal - The proposal aimed to raise the president's basic salary from 650,000 yuan to 910,000 yuan per year, which had not been adjusted since 2016 [2][8]. - The proposal received 24.088 million shares in favor, accounting for 33.127% of the votes, while 55.02 million shares were against it, and 48.076 million shares were abstentions [2][8][9]. Group 3: Shareholder Dynamics - The abstentions included 82,200 shares from minority shareholders, while the majority of abstentions came from shareholders holding more than 5%, aligning with the holdings of the fourth largest shareholder, Shanghai Xuhui City Development Group [3][9]. - Jiaotong Angli is recognized as the "first stock of health products" in A-shares, focusing on the research, production, and sales of health products and elderly care services [3][9]. Group 4: Leadership and Control - The current president, Ji Lin, is also the actual controller of Jiaotong Angli, holding approximately 30.06% of the company's total shares, valued at around 1.489 billion yuan based on the current stock price [5][11]. - Ji Lin has been involved in significant share acquisitions since 2021, leading to a change in control of the company [5][11].

致：上海交大昂立股份有限公司 上海交大昂立股份有限公司（以下简称"公司"）2025年第二次临时股东会（以下简称"本次股东会"）于 2025年12月30日14:30，在上海市徐汇区田州路99号13号楼11楼召开，北京双安律师事务所（以下简 称"本所"）接受公司的委托，指派席向阳律师、张丽华律师（以下简称"本所律师"）出席会议，并依据 《中华人民共和国公司法》（以下简称《公司法》）、《中华人民共和国证券法》（以下简称《证券 法》）、《上市公司股东会规则》（以下简称《股东会规则》）等相关法律、法规、规范性文件以及 《上海交大昂立股份有限公司章程》（以下简称《公司章程》）出具本法律意见书。 本所律师按照有关法律、法规、规范性文件的规定，对公司本次股东会召集、召开程序是否符合法律、 法规、规范性文件和《公司章程》的规定，出席会议人员的资格、召集人资格是否合法有效，以及会议 的表决程序、表决结果是否合法有效，发表法律意见。 本所及本所律师依据《证券法》、《律师事务所从事证券法律业务管理办法》和《律师事务所证券法律 业务执业规则(试行)》等规定及本法律意见书出具日以前已经发生或者存在的事实，严格履行了法定职 责，遵循了勤勉 ...

证券代码：600530 证券简称：交大昂立 公告编号：2025-055 上海交大昂立股份有限公司 2025年第二次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：有 一、 会议召开和出席情况 (一) 股东会召开的时间：2025 年 12 月 30 日 (二) 股东会召开的地点：上海市徐汇区田州路 99 号 13 号楼 11 楼 (三) 出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 201 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 305,670,427 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 39.4454 | (四) 表决方式是否符合《公司法》及《公司章程》的规定，会议主持情况等。 本次股东会由公司董事会召集、董事长嵇敏先生主持，本次股东会采用现场投票和 网络投票相结合的表决方式。本次股东会的召集、召开以及 ...

北京双安律师事务所 关于上海交大昂立股份有限公司 2025年第二次临时股东会的 法律意见书 致：上海交大昂立股份有限公司 上海交大昂立股份有限公司（以下简称"公司"）2025年第 二次临时股东会（以下简称"本次股东会"）于2025年12月30日 14:30，在上海市徐汇区田州路99号13号楼11楼召开，北京双安 律师事务所（以下简称"本所"）接受公司的委托，指派席向阳 律师、张丽华律师（以下简称"本所律师"）出席会议，并依据 《中华人民共和国公司法》（以下简称《公司法》）、《中华人民 共和国证券法》（以下简称《证券法》）、《上市公司股东会规则》 （以下简称《股东会规则》）等相关法律、法规、规范性文件以及 《上海交大昂立股份有限公司章程》（以下简称《公司章程》）出 具本法律意见书。 本所律师按照有关法律、法规、规范性文件的规定，对公司本 次股东会召集、召开程序是否符合法律、法规、规范性文件和《公 司章程》的规定，出席会议人员的资格、召集人资格是否合法有效， 以及会议的表决程序、表决结果是否合法有效，发表法律意见。 本所及本所律师依据《证券法》、《律师事务所从事证券法律 业务管理办法》和《律师事务所证券法律业务执 ...

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 600381 | *ST春天 | 4.31 | 1.65% | 6.48万 | 2767.69万 | | 000529 | 广弘控股 | 6.22 | 1.47% | 15.93万 | 9925.70万 | | 600530 | 交大昂立 | 6.57 | 0.92% | 7.58万 | 5014.16万 | | 000639 | 西王食品 | 3.52 | 0.28% | 1 78.03万 | 2.76亿 | | 002726 | 龙大美食 | 4.22 | 0.24% | 13.90万 | 5853.90万 | | 002330 | 得利斯 | 5.20 | 0.19% | 53.56万 | 2.81亿 | | 603345 | 安井食品 | 81.27 | -0.31% | 3.36万 | 2.74亿 | | 603262 | 技源集团 | 28.17 | -0.32% | 9349.43 | 2631.25万 | | 002840 | 华统 ...

上海交大昂立股份有限公司 2025 年第二次临时股东会 会议资料 二○二五年十二月 | | | | 一、2025 | 年第二次临时股东会会议议程·······································1 | | --- | --- | | 二、2025 | 年第二次临时股东会须知···········································2 | | | 三、审议本次股东会议案·················································4 | | | 1、关于聘任会计师事务所的议案·········································4 | | | 2、关于调整总裁岗位基本薪酬的议案······································7 | | | 3、关于修订《董事、高级管理人员薪酬管理制度》的议案·······················8 | 上海交大昂立股份有限公司 2025 年第二次临时股东会会议议程 会议召开时间： 现场会议时间：2025 年 12 月 30 ...

Core Viewpoint - The Hong Kong Stock Exchange announced the inclusion of 73 stocks into the Shanghai Stock Connect and 108 stocks into the Shenzhen Stock Connect, effective December 22, 2025, which may enhance liquidity and investment opportunities for these companies [1]. Shanghai Stock Connect - A total of 73 stocks, including Shanghai Jiao Tong University Anli Co., Ltd. (600530), Xiamen XGMA Machinery Co., Ltd. (600815), and Shanghai Yaohua Glass Group Co., Ltd. (600819), will be included in the Shanghai Stock Connect [1][3]. - The effective date for these inclusions is set for December 22, 2025 [1][3]. Shenzhen Stock Connect - A total of 108 stocks, including Fiyta Precision Technology Co., Ltd. (000026) and Chuangyuan Technology Co., Ltd. (000551), will be included in the Shenzhen Stock Connect [1][10]. - The effective date for these inclusions is also December 22, 2025 [1][10].

Group 1 - The company is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, with a formal notice received on July 11 [1][2] - This is the second time the company has been subjected to regulatory investigation, with the first case resulting in a penalty decision from the CSRC in November 2023 for failing to disclose relevant reports in a timely manner [2][4] - Investors who purchased shares before the announcement of the investigation may seek compensation through legal channels for losses incurred due to false statements made by the company [3][4] Group 2 - Two categories of investors are eligible to participate in the compensation claims: those who bought shares between April 22, 2017, and April 26, 2023, and sold or still hold them after April 27, 2023, and those who bought shares before July 11, 2025, and sold or still hold them after July 12, 2025 [2][4] - The CSRC maintains a "zero tolerance" policy to uphold market order and protect investors' rights, encouraging affected investors to take action [2][4] - The lawyer representing the claims has extensive experience in securities rights protection, having successfully represented over 300 companies and handled more than 14,000 cases with a high success rate [2][4]